Jeffrey D. Marrazzo's most recent trade in Prime Medicine Inc was a trade of 250,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 250,000 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 92,000 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 92,000 | 92,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Aug 2025 | 45,000 | 0 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 800,000 | 800,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Prime Medicine Inc | Jeffrey D. Marrazzo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 92,000 | 92,000 | - | - | Stock Option (right to buy) |